The development of new therapies involves several stages, starting with preclinical research and moving on to clinical trials. Preclinical research includes laboratory and animal studies to assess the safety and biological activity of the therapy. Clinical trials are conducted in multiple phases (Phase I, II, III, and IV) to evaluate the therapy's safety, efficacy, and optimal dosing in humans. Regulatory approvals are sought before the therapy can be made available to the public.
